Bioceltix

Bioceltix Market capitalization

The The market capitalization of Bioceltix (BCX.WA) as of Oct 21, 2026 is 474.67 M PLN. In the previous year, The market capitalization was 474.67 M PLN — a change of 0.00% (lower).

Market capitalization

474.67 MPLN

YoY

0.00%

Last updated:

In 2025, Bioceltix's market cap stood at 474.67 M PLN, a 0.00% increase from the 474.67 M PLN market cap in the previous year.

The Bioceltix Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
474.67 M PLN
Jan 1, 2019
474.67 M PLN
Jan 1, 2020
474.67 M PLN
Jan 1, 2021
474.67 M PLN
Jan 1, 2022
474.67 M PLN
Jan 1, 2023
474.67 M PLN
Jan 1, 2024
474.67 M PLN
Jan 1, 2025
474.67 M PLN
The Bioceltix Market capitalization history
YEARMarket capitalizationYoY
474.67 MPLN0.00%
474.67 MPLN0.00%
474.67 MPLN0.00%
474.67 MPLN0.00%
474.67 MPLN0.00%
474.67 MPLN0.00%
474.67 MPLN0.00%
474.67 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioceltix Stock analysis

What does Bioceltix do? Bioceltix SA focuses on research and development within the field of veterinary medicine, specifically targeting the treatment of companion animals. The company develops candidates for veterinary medicinal products by utilizing the immunomodulatory properties of mesenchymal stem cells as the active substance. This scientific approach allows the firm to conduct research and development works that facilitate clinical trials and the full registration of these medicinal products with the European Medicines Agency, adhering to standards similar to those for human medicines. Bioceltix is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Bioceltix's Market Capitalization

Bioceltix's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Bioceltix's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Bioceltix's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Bioceltix’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Bioceltix stock

The market capitalization of Bioceltix is 474.67 M PLN in 2025.

The market capitalization of Bioceltix changed from 474.67 M PLN to 474.67 M PLN, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Bioceltix since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's PLN, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' PLN varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Bioceltix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Bioceltix

All Key Metrics — Bioceltix